Sarissa Capital Management LP

Q3 2025 13F Holdings

  • Location
    greenwich, CT
  • Num holdings

    8

  • Value ($000)

    $180,392

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001577524
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
INVA
INVA

INNOVIVA INC

COM
$51.39 M
29 %

2,816,022

NBIX
NBIX

NEUROCRINE BIOSCIENCES INC

COM
$42.56 M
24 %

303,151

CYTK
CYTK

CYTOKINETICS INC

COM NEW
$32.34 M
18 %

588,357

IRWD
IRWD

IRONWOOD PHARMACEUTICALS INC

COM CL A
$20.85 M
12 %

15,919,435

---

AMARIN CORP PLC

SPONSORED ADR
$20.35 M
11 %

1,242,527

LNTH
LNTH

LANTHEUS HLDGS INC

COM
$9.31 M
5 %

181,450

REGN
REGN

REGENERON PHARMACEUTICALS

COM
$2.36 M
1 %

4,190

---

VOR BIOPHARMA INC

COM NEW
$1.24 M
1 %

25,399

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 8 of 8